When should I file a claim?

Colorado’s statute of limitations on filing a personal injury claim is two years. Colorado operates under the discovery rule, meaning that the clock starts ticking from the time the injury is discovered, not from when it initially occurred.

How can I prove negligence?

Colorado operates under the contributory negligence rule, which means that the person who injured you may file a counter-claim for damages if they believe that you, the injured, were also partially at fault.

When will the other person’s insurance contact me?

Colorado law stipulates that insurance is not allowed to contact you within 30 days of being injured. A release of liability, which is a statement that says you won’t sue the at-fault party for anything else, can’t be obtained by insurance within 30 days either.

Justice for You

free case consultation

Colorado Taxotere Lawyer

Taxotere, a chemotherapy drug, has been linked to some serious complications, including permanent hair loss in some patients. At least one manufacturer, Sanofi-Aventis (Sanofi), is now the center of a national investigation to uncover whether the risk of permanent alopecia was known before this drug was brought to market – and whether Sanofi failed to warn patients about this significant risk.

The experienced dangerous drug lawyers at Killian, Davis, Richter & Fredenburg, PC are currently accepting and investigating claims of permanent baldness related to Taxotere exposure. If you or someone you love has taken Taxotere and is now experiencing permanent alopecia, contact Killian, Davis, Richter & Fredenburg, PC for a free case evaluation to find out more about your options for financial recovery.

BACKGROUND: WHAT IS TAXOTERE?

Approved by the U.S. Food & Drug Administration (FDA) in 19961, Taxotere (docetaxel) is an intravenous chemotherapy drug that is prescribed in the treatment of breast cancer (and certain other cancers) and that is commonly administered along with other chemotherapy medications.

While Taxotere may be administered to women with early- to late-stage breast cancer, in general, it is used following surgery when:

Patients are not responding to Doxorubicin (another chemotherapy drug); and/or
Breast cancer has metastasized (i.e., spread to other regions of the body).

TAXOTERE LINKED TO PERMANENT HAIR LOSS

Although Taxotere is associated with a number of relatively mild side effects, such as nausea and vomiting, recent findings suggest that this chemotherapy drug may also be causing permanent baldness in some patients.

In fact, mounting reports reveal that some chemotherapy patients exposed to Taxotere are unable to regrow hair despite the fact that Taxotere warning labels indicate that hair loss should only be temporary.

The National Institutes of Health (NIH)2 have even pointed out that there is an increasing amount of evidence establishing a link between certain chemotherapy regimens (such as those that include Taxotere) and “dose-dependent permanent alopecia.” At this point, researchers believe that the duration of Taxotere exposure, along with the dosage administered, are just some of the primary factors that may be contributing to permanent alopecia in some breast cancer patients.

For those who have reported experiencing permanent baldness following the use of Taxotere, some have described these impacts as being a sort of scarlet letter or permanent branding that has marked them as cancer survivors for life.

FDA WARNINGS ABOUT TAXOTERE

While the links between Taxotere use and permanent alopecia are a relatively new finding about the potential complications associated with this chemotherapy drug, it is important to note that this drug has had a rocky history with regulators in the U.S.

In fact, over recent years, officials at the FDA have issued at least two important warnings regarding Taxotere:

In November 2003, the FDA sent a warning letter to the drug maker, pointing out that the printed materials for Taxotere overstated the efficacy of the drug and made “misleading” and “unsubstantiated” claims about it.
In June 2014, the FDA issued public safety communication, alerting patients that Taxotere contains ethanol and that use of this drug can result in symptoms of alcohol impairment. At that time, regulators also urged medical professionals to consider ethanol exposure levels when administering Taxotere with other medications (especially those that may also contain ethanol).

As reports of permanent alopecia related to Taxotere use grow, the FDA may soon issue a new warning about this complication.

CONTACT A GRAND JUNCTION PERSONAL INJURY ATTORNEY AT KILLIAN, DAVIS, RICHTER & KRANIAK, PC

If you have developed permanent baldness after being exposed to Taxotere – or if you have developed any serious complications after taking any potentially dangerous drug, contact an experienced Grand Junction personal injury attorney at Killian, Davis, Richter & Fredenburg, PC for aggressive, effective legal advocacy moving forward.

For well over three decades, our lawyers have been dedicated fighting for our clients’ rights, advancing their interests and helping them succeed in their pursuit of justice and financial recovery.

To receive professional advice regarding your case and your options for proceeding, schedule a free, no obligations initial consultation with us today by calling (970) 241-0707 or by sending us an email via the contact form on this page. We will not charge you anything until or unless there is an award or settlement secured for your case. So, you have nothing to lose by contacting us today to find out more about your legal rights and options.

1: Initial FDA approval of Taxotere

2: Permanent alopecia after systemic chemotherapy, NIH